Vascular degeneration in parkinsons disease

Brain Pathology

Volumn 23, Issue 2, 2013, Pages 154-164

  Guan, Jian ^a   Pavlovic, Darja ^a,b   Dalkie, Nicholas ^b   Waldvogel, Henry J ^b   O'Carroll, Simon J ^b   Green, Colin R ^b   Nicholson, Louise F B ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

endothelial clusters; factor VIII; human cases; Parkinson's disease; vascular degeneration

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD VESSEL DEGENERATION; BRAIN DEGENERATION; BRAIN REGION; BRAIN TISSUE; CAUDATE NUCLEUS; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; PARKINSON DISEASE; VASCULAR DISEASE; BRAIN; NERVE DEGENERATION; PATHOLOGY; VASCULAR ENDOTHELIUM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN; CAUDATE NUCLEUS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; NERVE DEGENERATION; PARKINSON DISEASE;

EID: 84874486429     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2012.00628.x     Document Type: Article

References (41)

1. Abe Y, Yamamoto T, Soeda T, Kumagai T, Tanno Y, Kubo J, et al (2009) Diabetic striatal disease: clinical presentation, neuroimaging, and pathology. Intern Med 48: 1135-1141.
2. Arganda-Carreras I, Fernández-González R, Muñoz-Barrutia A, Ortiz-De-Solorzano C, (2010) 3D reconstruction of histological sections: application to mammary gland tissue. Microsc Res Tech 73: 1019-1029.
3. Aston-Jones G, Shipley MT, Chouvet G, Ennis M, van, Bockstaele E, Pieribone V, et al (1991) Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog Brain Res 88: 47-75.
4. Bell RD, Winkler EA, Sagare AP, Singh I, LaRue B, Deane R, Zlokovic BV, (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68: 409-427.
5. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, et al (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485: 512-516.
6. de Jong LW, Wang Y, White LR, Yu B, van, Buchem MA, Launer LJ, (2012) Ventral striatal volume is associated with cognitive decline in older people: a population based MR-study. Neurobiol Aging 33: 424. e10.
7. de Lau LM, Breteler MM, (2006) Epidemiology of Parkinson's disease. Lancet Neurol 5: 525-535.
8. Desai Bradaric B, Patel A, Schneider JA, Carvey PM, Hendey B, (2012) Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy. J Neural Transm 119: 59-71.
9. Faucheux BA, Bonnet AM, Agid Y, Hirsch EC, (1999) Blood vessels change in the mesencephalon of patients with Parkinson's disease. Lancet 353: 981-982.
10. Fernandez-Seara MA, Mengual E, Vidorreta M, Aznarez-Sanado M, Loayza FR, Villagra F, et al (2012) Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI. Neuroimage 59: 2743-2750.
11. Guan J, Zhang R, (2011) Age-related vascular degeneration and memory decline. In: The 10th International Conference on Alzheimer's and Parkinson's diseases Barcelona, Spain.
12. Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RG, Howe PR, et al (1990) Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 27: 373-385.
13. Hattiangady B, Shetty AK, (2008) Aging does not alter the number or phenotype of putative stem/progenitor cells in the neurogenic region of the hippocampus. Neurobiol Aging 29: 129-147.
14. Hirase H, (2005) A multi-photon window onto neuronal-glial-vascular communication. Trends Neurosci 28: 217-219.
15. Intaglietta M, Johnson PC, Winslow RM, (1996) Microvascular and tissue oxygen distribution. Cardiovasc Res 32: 632-643.
16. Isaias IU, Marzegan A, Pezzoli G, Marotta G, Canesi M, Biella GE, et al (2011) A role for locus coeruleus in Parkinson tremor. Front Hum Neurosci 5: 179, 1-9.
17. Iseki E, (2004) Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease. Neuropathology 24: 72-78.
18. Ishitsuka K, Ago T, Arimura K, Nakamura K, Tokami H, Makihara N, et al (2012) Neurotrophin production in brain pericytes during hypoxia: a role of pericytes for neuroprotection. Microvasc Res 83: 352-359.
19. Jacobson J, Zhang R, Elliffe D, Chen K, Mathai S, McCarthy D, et al (2008) Co-relation of cellular changes and spatial memory during aging in rats. Exp Gerontol 43: 928-938.
20. Kageyama T, Nakamura M, Matsuo A, Yamasaki Y, Takakura Y, Hashida M, et al (2000) The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Res 879: 115-121.
21. Kannurpatti SS, Motes MA, Rypma B, Biswal BB, (2010) Neural and vascular variability and the fMRI-BOLD response in normal aging. Magn Reson Imaging 28: 466-476.
22. Kortekaas R, Leenders KL, van, Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH, (2005) Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 57: 176-179.
23. Lindner MD, Cain CK, Plone MA, Frydel BR, Blaney TJ, Emerich DF, Hoane MR, (1999) Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats. Behav Brain Res 102: 1-16.
24. Liu L, Su Y, Yang W, Xiao M, Gao J, Hu G, (2010) Disruption of neuronal-glial-vascular units in the hippocampus of ovariectomized mice injected with d-galactose. Neuroscience 169: 596-608.
25. Mann GE, Zlokovic BV, Yudilevich DL, (1985) Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon. Biochim Biophys Acta 819: 241-248.
26. Marchesi VT, (2011) Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy. FASEB J 25: 5-13.
27. Mattar EH, Haffor AS, (2009) Effect of dobutamine and hyperoxia on free radicals production in relation to the ultrastructural alterations in the endothelial of myocardial capillary in rats, Rattus norvigicus. Ultrastruct Pathol 33: 209-215.
28. McMillan PJ, White SS, Franklin A, Greenup JL, Leverenz JB, Raskind MA, Szot P, (2011) Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease. Brain Res 1373: 240-252.
29. Poewe W, (2009) Treatments for Parkinson disease-past achievements and current clinical needs. Neurology 72 (Suppl 7): S65-S73.
30. Quaegebeur A, Lange C, Carmeliet P, (2011) The neurovascular link in health and disease: molecular mechanisms and therapeutic implications. Neuron 71: 406-424.
31. Rodriguez JJ, Olabarria M, Chvatal A, Verkhratsky A, (2009) Astroglia in dementia and Alzheimer's disease. Cell Death Differ 16: 378-385.
32. Sharp SI, Francis PT, Elliott MS, Kalaria RN, Bajic N, Hortobagyi T, Ballard CG, (2009) Choline acetyltransferase activity in vascular dementia and stroke. Dement Geriatr Cogn Disord 28: 233-238.
33. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, et al (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304: 1338-1340.
34. Waldvogel HJ, Curtis MA, Baer K, Rees MI, Faull RLM, (2007) Immunohistochemical staining of post-mortem adult human brain sections. Nat Protocols 1: 2719-2732.
35. Wang P, Xie ZH, Guo YJ, Zhao CP, Jiang H, Song Y, et al (2011) VEGF-induced angiogenesis ameliorates the memory impairment in APP transgenic mouse model of Alzheimer's disease. Biochem Biophys Res Commun 411: 620-626.
36. Wolburg H, Noell S, Mack A, Wolburg-Buchholz K, Fallier-Becker P, (2009) Brain endothelial cells and the glio-vascular complex. Cell Tissue Res 335: 75-96.
37. Zarow C, Lyness SA, Mortimer JA, Chui HC, (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60: 337-341.
38. Zlokovic BV, (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12: 723-738.
39. Zlokovic BV, Apuzzo ML, (1997) Cellular and molecular neurosurgery: pathways from concept to reality-part I: target disorders and concept approaches to gene therapy of the central nervous system. Neurosurg 40: 789-803. discussion 4.
40. Zlokovic BV, Mackic JB, Djuricic B, Davson H, (1989) Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea-pig brain. J Neurochem 53: 1333-1340.
41. Zlokovic BV, Segal MB, Begley DJ, Davson H, Rakic L, (1985) Permeability of the blood-cerebrospinal fluid and blood-brain barriers to thyrotropin-releasing hormone. Brain Res 358: 191-199.